mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal new junction evidence (lowest skew 10 of 11 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NZ_CP009273 | 1972967 = | 1 (0.010) | 50 (0.440) | 26/474 | 4.5 | 98.0% | intergenic (‑513/‑267) | flhD/uspC | flagellar transcriptional regulator FlhD/universal stress protein UspC |
| ? | NZ_CP009273 | 2095230 = | NA (NA) | pseudogene (1/354 nt) | wbbL | N‑acetylglucosaminyl‑diphospho‑decaprenol L‑rhamnosyltransferase WbbL | |||||
| * | ? | NZ_CP009273 | = 4532507 | 8 (0.070) | 5 (0.050) | 5/456 | 11.5 | 16.8% | intergenic (+57/‑425) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA |
| ? | NZ_CP009273 | = 4532803 | 42 (0.380) | intergenic (+353/‑129) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA | |||||
| * | ? | NZ_CP009273 | = 2320388 | 92 (0.800) | 5 (0.050) | 5/458 | 11.5 | 5.4% | coding (801/1185 nt) | atoB | acetyl‑CoA acetyltransferase |
| ? | NZ_CP009273 | = 2320423 | 86 (0.780) | coding (836/1185 nt) | atoB | acetyl‑CoA acetyltransferase | |||||
| * | ? | NZ_CP009273 | 1209039 = | 166 (1.450) | 4 (0.040) | 4/454 | 12.1 | 2.5% | coding (477/732 nt) | bluR | DNA‑binding transcriptional repressor BluR |
| ? | NZ_CP009273 | 1209089 = | 147 (1.340) | coding (427/732 nt) | bluR | DNA‑binding transcriptional repressor BluR | |||||
| * | ? | NZ_CP009273 | = 4008607 | 124 (1.080) | 4 (0.040) | 4/460 | 12.2 | 3.2% | coding (2195/2262 nt) | metE | 5‑methyltetrahydropteroyltriglutamate‑‑ homocysteine S‑methyltransferase |
| ? | NZ_CP009273 | = 4008619 | 120 (1.080) | coding (2207/2262 nt) | metE | 5‑methyltetrahydropteroyltriglutamate‑‑ homocysteine S‑methyltransferase | |||||
| * | ? | NZ_CP009273 | = 2213096 | 105 (0.920) | 4 (0.040) | 4/462 | 12.2 | 3.7% | intergenic (‑136/+75) | osmF/bglX | glycine betaine ABC transporter substrate‑binding protein OsmF/beta‑glucosidase BglX |
| ? | NZ_CP009273 | = 2213103 | 106 (0.950) | intergenic (‑143/+68) | osmF/bglX | glycine betaine ABC transporter substrate‑binding protein OsmF/beta‑glucosidase BglX | |||||
| * | ? | NZ_CP009273 | = 1280805 | 102 (0.890) | 4 (0.040) | 4/458 | 12.2 | 3.9% | coding (211/711 nt) | narJ | nitrate reductase molybdenum cofactor assembly chaperone |
| ? | NZ_CP009273 | = 1280852 | 97 (0.880) | coding (258/711 nt) | narJ | nitrate reductase molybdenum cofactor assembly chaperone | |||||
| * | ? | NZ_CP009273 | 1406156 = | 122 (1.070) | 3 (0.030) | 3/422 | 12.3 | 3.3% | coding (50/936 nt) | ttcA | tRNA 2‑thiocytidine(32) synthetase TtcA |
| ? | NZ_CP009273 | = 1429215 | 66 (0.650) | intergenic (‑552/+227) | BW25113_RS25575/uspF | hypothetical protein/universal stress protein UspF | |||||
| * | ? | NZ_CP009273 | = 3064900 | 150 (1.310) | 3 (0.030) | 3/450 | 12.8 | 2.0% | coding (1082/1164 nt) | pgk | phosphoglycerate kinase |
| ? | NZ_CP009273 | 3064970 = | 145 (1.330) | coding (1012/1164 nt) | pgk | phosphoglycerate kinase | |||||
| * | ? | NZ_CP009273 | = 2473113 | 133 (1.190) | 3 (0.030) +ACT |
3/458 | 12.9 | 2.2% | coding (433/1329 nt) | dsdA | D‑serine ammonia‑lyase |
| ? | NZ_CP009273 | 2473114 = | 134 (1.170) | coding (434/1329 nt) | dsdA | D‑serine ammonia‑lyase | |||||